EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Surgical Therapy for Local Recurrence and Oligometastatic Urothelial Carcinoma of the Bladder: 20 Years of Experience in a Tertiary Center

Mulham Al-Nader, Ulrich Krafft, Christopher Darr, Jochen Heß, Claudia Kesch, Lukas Püllen, Stephan Tschirdewahn, Umut-Ulas Yesilyurt, Aykhan Isgandarov, Boris Hadaschik, Osama Mahmoud

Urologia Internationalis · 2024

DOI: 10.1159/000542982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Urologia Internationalis, 2024. Verfasst von Mulham Al-Nader und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Essen, Essen, Germany. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Neoplasm Recurrence, Local, Cystectomy, Carcinoma, Transitional Cell. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The impact of surgical therapy on selected patients with limited metastatic/recurrence burden has not yet been well studied. We investigated the outcome of surgical resection for patients with local recurrence only or oligometastatic urothelial carcinoma (UC) of the bladder.

Methods

We identified patients with oligometastatic UC or local recurrence only after radical cystectomy who underwent surgical resection with curative intent between 2003 and 2022 at our center. Oligometastatic UC was defined as three or fewer resectable lesions, regardless of the number of organs involved. We studied the surgical outcome, progression-free survival (PFS) and overall survival (OS) in this selected group of patients.

Results

A total of 39 patients were selected, including 18 (46%) with local recurrence and 21 (54%) with oligometastatic UC. Nine patients (23%) experienced intraoperative complications, all of whom belonged to the local recurrence group, while 8 patients (20.5%) experienced major postoperative complications, including 6 patients from the local recurrence group and 2 patients with oligometastatic disease. The median PFS following surgery was 19 months (95% CI; 2.5–35.5) with 1- and 3-year progression rates of 47% and 29%, while the median OS was 24 months (95% CI; 8.6–39.3) with 1- and 3-year survival rates of 51% and 30%. A significantly better median PFS was observed in the metastatic versus local recurrence group (35 vs. 8 months, p = 0.01). Similarly, a median OS of 41 months was observed in the metastatic group compared to only 12 months for the local recurrence group (p = 0.12). Overall, a better survival time of 30 months was observed in the metachronous group compared to 6 months in the synchronous group (p = 0.046). In a further analysis of the metastatic group, metachronous oligometastasis was associated with a longer survival of 43 months compared to 9 months for synchronous metastasis (p = 0.18). Some differences were not significant, which may be due to sample size.

Conclusion

Our study shows reasonable surgical and survival outcomes of metastasectomy, especially in the metachronous subgroup, for UC without risk of higher perioperative morbidity. On the other hand, resection of local recurrence is associated with a higher risk of incomplete resection and higher intraoperative and postoperative morbidity without offering a survival benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsNeoplasm Recurrence, LocalCystectomyCarcinoma, Transitional CellHumansMaleFemaleAgedMiddle AgedTreatment OutcomeRetrospective StudiesTertiary Care CentersTime FactorsNeoplasm MetastasisAged, 80 and overSurvival Rate

Stichwörter der Autor:innen

MetastasectomyOligometastaticRecurrent bladder cancer

Autor:innen und Institutionen

  • Department of Urology, University Hospital Essen, Essen, Germany.
  • Department of Urology, University Hospital Essen, Essen, Germany, ulrich.krafft@uk-essen.de.
  • Department of Urology, South Valley university, Qena, Egypt.

Zitieren

APA

Al-Nader, M., Krafft, U., Darr, C., Heß, J., Kesch, C., Püllen, L., Tschirdewahn, S., Yesilyurt, U. U., Isgandarov, A., Hadaschik, B., & Mahmoud, O. (2024). Outcomes of Surgical Therapy for Local Recurrence and Oligometastatic Urothelial Carcinoma of the Bladder: 20 Years of Experience in a Tertiary Center. Urologia Internationalis. https://doi.org/10.1159/000542982

Vancouver

Al-Nader M, Krafft U, Darr C, Heß J, Kesch C, Püllen L, et al. Outcomes of Surgical Therapy for Local Recurrence and Oligometastatic Urothelial Carcinoma of the Bladder: 20 Years of Experience in a Tertiary Center. Urologia Internationalis. 2024. doi:10.1159/000542982

BibTeX
@article{AlNader2024,
  author = {Al-Nader, Mulham and Krafft, Ulrich and Darr, Christopher and Heß, Jochen and Kesch, Claudia and Püllen, Lukas and Tschirdewahn, Stephan and Yesilyurt, Umut-Ulas and Isgandarov, Aykhan and Hadaschik, Boris and Mahmoud, Osama},
  title = {Outcomes of Surgical Therapy for Local Recurrence and Oligometastatic Urothelial Carcinoma of the Bladder: 20 Years of Experience in a Tertiary Center},
  journal = {Urologia Internationalis},
  year = {2024},
  doi = {10.1159/000542982}
}
Kostenlos starten →